Alpha-Lipoic Acid Injection 5ml:125mg

Alpha-Lipoic Acid Injection 5ml:125mg: What the Published Guidance Says

Our largest functional group by product count — from the individual vitamins and minerals carried on the WHO Model List through to parenteral nutrition components and finished multivitamin presentations.

This page collects the supply-relevant facts for Alpha-Lipoic Acid Injection 5ml:125mg — specification, testing, packaging and the registration paperwork that travels with the batch.

• The economic case for essential medicines is documented WHO reports that medicines account for 20–60% of health spending in developing countries, with up to 90% of the population purchasing medicines through out-of-pocket payments, making medicines the largest family expenditure item after food. The 2025 Model List covers over 520 medicines, including 374 for children. WHO — Essential medicines (fact sheet)
• Anaemia prevention is a listed intervention Ferrous salt with folic acid appears on the Model List as an antianaemia medicine, in tablet form. Folic acid and iron are the standard pair used in national supplementation programmes, and matching your market's programme strength matters. WHO — Essential medicines (fact sheet)
• The Model List sections that carry this portfolio Vitamins and minerals sit in section 27 of the 24th WHO Model List (2025). The listings include ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol, alongside calcium and other minerals. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)

Each point above is reproduced because it has a practical consequence for Alpha-Lipoic Acid Injection 5ml:125mg: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

How Alpha-Lipoic Acid Injection 5ml:125mg Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for Alpha-Lipoic Acid Injection 5ml:125mg follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

• Testing for related substances and impurities
• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How Alpha-Lipoic Acid Injection 5ml:125mg Is Packed, Labelled and Shipped

• Pack size: 5mL amber type I glass ampoule (light-protected). Non-standard pack sizes can be quoted against your artwork.
• Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoules in outer carton until use. The product is light-sensitive; minimize exposure to light during administration..
• Shelf life: 24 months (unopened). Stability data for the marketed pack is included in the dossier.
• Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
• Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for Alpha-Lipoic Acid Injection 5ml:125mg

The legal manufacturer named on every document for Alpha-Lipoic Acid Injection 5ml:125mg is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

• Batch manufacturing and packaging records released for inspection on request during supplier audits.
• Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
• CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
• Site Master File and GMP certificate for the manufacturing workshops.
• Method validation, stability protocol and the shelf-life justification for the marketed pack.

Alpha-Lipoic Acid Injection 5ml:125mg is presented here against vitamins, minerals and clinical nutrition products named in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.